Hildebrandt Isabella, Rudinsky Adam, Parker Valerie, Winston Jenessa, Wood Alexandra, Evans Samantha, Howard James
Department of Veterinary Clinical Sciences, The Ohio State University, 601 Vernon L Tharp St., 43210 Columbus, OH, USA.
Comparative Hepatobiliary and Intestinal Research Program, The Ohio State University, Columbus, OH, USA.
Case Rep Vet Med. 2021 Dec 9;2021:5808886. doi: 10.1155/2021/5808886. eCollection 2021.
An 11-year-old male castrated domestic shorthair cat was presented for evaluation due to clinical deterioration and potential extrahepatic biliary obstruction (EHBO). Further investigations confirmed EHBO and revealed severe and previously unreported comorbidities. On initial examination, the cat was markedly icteric with a poor body condition score and severe muscle wasting. Serum chemistry and complete blood count showed evidence of cholestasis and anemia. Primary diagnostics and therapeutics targeted these abnormalities. Abdominal ultrasound revealed peritoneal effusion, multifocal mixed echogenic hepatic and splenic foci, small intestinal thickening, cholelithiasis, choledocholithiasis, and common bile duct and pancreatic duct dilation with evidence of obstruction. Peritoneal effusion cytology confirmed septic peritonitis. Hepatic and splenic cytology was consistent with lymphoma. Based on these results, euthanasia was elected by the owners of the animal. Necropsy confirmed the ultrasound diagnoses, septic peritoneal effusion associated with a duodenal perforation, multiorgan lymphoma, and common bile duct carcinoma. Flow cytometry classified the lymphoma as a double-negative phenotype of T-cell lymphoma (CD3+ and CD5+, but CD4- and CD8-) present in the duodenum and liver and suspected in the spleen which has previously not been reported in cats. This case report documents a cat with EHBO caused by multiple disease processes including a novel T-cell lymphoma phenotype, biliary carcinoma, duodenal perforation and septic abdomen, and choleliths, as well as inflammatory hepatobiliary disease.
一只11岁已绝育的家养短毛雄性猫因临床病情恶化及可能存在的肝外胆管阻塞(EHBO)前来接受评估。进一步检查证实了EHBO,并发现了严重且此前未报告的合并症。初次检查时,这只猫黄疸明显,身体状况评分很低,且有严重的肌肉消瘦。血清生化检查和全血细胞计数显示有胆汁淤积和贫血的迹象。初步诊断和治疗针对这些异常情况。腹部超声检查发现有腹腔积液、肝脏和脾脏多处混合回声灶、小肠增厚、胆石症、胆总管结石、胆总管和胰管扩张并有梗阻迹象。腹腔积液细胞学检查证实为败血性腹膜炎。肝脏和脾脏细胞学检查结果与淋巴瘤相符。基于这些结果,动物主人选择了实施安乐死。尸检证实了超声检查的诊断结果,即与十二指肠穿孔相关的败血性腹腔积液、多器官淋巴瘤以及胆总管癌。流式细胞术将淋巴瘤分类为T细胞淋巴瘤的双阴性表型(CD阳性、CD5阳性,但CD4阴性和CD8阴性),存在于十二指肠和肝脏,脾脏也疑似存在这种情况,这在猫中此前尚未有过报道。本病例报告记录了一只因多种疾病过程导致EHBO的猫病例,这些疾病过程包括一种新型的T细胞淋巴瘤表型、胆管癌、十二指肠穿孔和败血性腹部疾病、胆石症以及炎症性肝胆疾病。